N6-(delta2-isopentenyl)adenosine 5'-monophosphate: formation and effect on purine metabolism in cellular and enzymatic systems.
D000227:Adenine Nucleotides / Q000032:analysis; D000249:Adenosine Monophosphate / Q000138:chemical synthesis / Q000378:metabolism* / Q000494:pharmacology; D000475:Alkenes / Q000138:chemical synthesis / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D002250:Carbon Radioisotopes; D002477:Cells / Q000187:drug effects; D002478:Cells, Cultured; D002854:Chromatography, Paper; D005998:Glycine / Q000378:metabolism; D007042:Hypoxanthines / Q000378:metabolism; D007292:Inosine Nucleotides; D007658:Ketone Oxidoreductases / Q000037:antagonists & inhibitors; D008025:Ligases / Q000037:antagonists & inhibitors; D008190:Lyases / Q000037:antagonists & inhibitors; D008727:Methotrexate / Q000494:pharmacology; D010430:Pentosyltransferases / Q000037:antagonists & inhibitors; D010770:Phosphotransferases / Q000378:metabolism; D011687:Purines / Q000037:antagonists & inhibitors / Q000378:metabolism*; D012510:Sarcoma 180 / Q000201:enzymology / Q000378:metabolism; D013997:Time Factors
D000227:Adenine Nucleotides; D000475:Alkenes; D002250:Carbon Radioisotopes; D007042:Hypoxanthines; D007292:Inosine Nucleotides; D011687:Purines; D000249:Adenosine Monophosphate; D007658:Ketone Oxidoreductases; D010430:Pentosyltransferases; D010770:Phosphotransferases; D008190:Lyases; D008025:Ligases; D005998:Glycine; D008727:Methotrexate